Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Glaxosmithkline Pharmaceuticals to focus on 20 brands, 5 therapeutic segments: Report

16 Jul 2019

GlaxoSmithKline Pharmaceuticals, the Indian unit of British drug major GSK, is reportedly planning to  focus its energies on 20 brands and 5 therapeutic segments anti-infectives, dermatology, respiratory, gastro-intestinal and anti-pyretic to drive future growth in India.

The drug maker is also looking for deeper engagement with distribution channel partners and securing control over the supply chain with its own factories.

GlaxoSmithKline Pharmaceuticals (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines.

Related Glaxosmithkline Pharmaceuticals Ltd. Links:

Glaxosmithkline Phar Share Price

1580.25 -3.80 (-0.24%) Jun 15, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 673.20
Dr. Reddys Lab 5414.90
Lupin 1186.65
Piramal Enterprises 2218.10
Cadila Healthcare 646.30
View more..
Sensex vs Glaxosmithkline Phar
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback